Drugs Containing Excipient (Inactive Ingredient) GLYCERYL ISOSTEARATE

Branded drugs containing GLYCERYL ISOSTEARATE excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Bausch Health US LLC	ERTACZO	sertaconazole nitrate	0187-5115	GLYCERYL ISOSTEARATE
Padagis Israel Pharmaceuticals Ltd	CLINDESSE	clindamycin phosphate	45802-042	GLYCERYL ISOSTEARATE
Lacer Pharma LLC	ERTACZO	sertaconazole nitrate	73159-004	GLYCERYL ISOSTEARATE

Generic drugs containing GLYCERYL ISOSTEARATE excipient

Company	Ingredient	NDC	Excipient
Bausch Health US LLC	sertaconazole nitrate	0187-5115	GLYCERYL ISOSTEARATE
Padagis Israel Pharmaceuticals Ltd	clindamycin phosphate	45802-042	GLYCERYL ISOSTEARATE
Padagis Israel Pharmaceuticals Ltd	butoconazole nitrate	45802-396	GLYCERYL ISOSTEARATE

GLYCERYL ISOSTEARATE Market Analysis and Financial Projection

Last updated: February 16, 2026

What is the Market Size and Growth for Glyceryl Isostearate?

Glyceryl isostearate (GI) is a popular cosmetic and pharmaceutical excipient used as an emollient and emulsifier. The global market for glyceryl isostearate was valued at approximately USD 135 million in 2022. It is projected to grow at a compound annual growth rate (CAGR) of around 4.5% from 2023 to 2030. The demand stems from its extensive application in skincare, haircare, and pharmaceutical formulations, driven by increasing consumer awareness of skincare products and rising pharmaceutical R&D activities.

What Are the Key Market Drivers?

Increasing Usage in Personal Care and Cosmetics

The cosmetic industry's evolution toward natural, skin-friendly ingredients boosts demand. Glyceryl isostearate offers excellent skin compatibility, moisturizing properties, and stability, making it appealing for formulating creams, lotions, and cleansers.

Rising Pharmaceutical Applications

Glyceryl isostearate is used as a solubilizer, viscosity stabilizer, and emulsifier in topical and oral pharmaceutical products. Growing pharmaceutical R&D, especially in dermatology and topical drug delivery, escalates demand.

Regulatory Environment Favorability

Given its classification as a Generally Recognized As Safe (GRAS) substance in various regions, regulatory restrictions are limited, facilitating market expansion.

Regional Market Trends

• North America: Leading market due to high cosmetic consumption and established pharma R&D infrastructure.
• Asia-Pacific: Fastest growth, driven by expanding consumers' skincare awareness and cosmetic manufacturing in China and India.

What Are the Challenging Factors?

Competition from Synthetic and Natural Alternatives

Glyceryl isostearate faces competition from plant-based emulsifiers like jojoba esters or shea butter derivatives.

Supply Chain Constraints

Availability of raw materials like isostearic acid influences pricing and supply stability.

Regulatory Variability

While broadly considered safe, emerging regional regulations on cosmetic ingredients may impact market access.

What Are the Financial Trajectories and Investment Opportunities?

Current Market Valuation

In 2022, manufacturers reported revenues in a range of USD 80 million to USD 150 million, with key players including Croda International, BASF, and Evonik Industries.

R&D and Innovation Investment

Major firms allocate 5-8% of their annual revenues toward R&D to develop eco-friendly and water-soluble variants. Investment in biobased glyceryl isostearate formulations aims to meet consumer demand for natural products.

Mergers and Acquisitions

Recent acquisitions, such as Croda's purchase of smaller biotech firms specializing in natural emollients, indicate strategic moves to diversify raw material sourcing and expand product portfolios.

Pricing Trends

Average prices have remained relatively stable over the past five years, with slight increases correlated to raw material costs. Bulk procurement and regional manufacturing reduce costs for large supply chain companies.

What Are Future Market Opportunities?

• Expansion into specialty formulations, including drug delivery systems.
• Development of biodegradable and plant-based variants to align with sustainability trends.
• Entry into emerging markets where cosmetic and pharmaceutical sectors are expanding rapidly.

Closing Analysis

Glyceryl isostearate exhibits steady growth prospects driven by its versatility and safety profile. The market aligns with expanding consumer demand for cosmetic products and pharmaceutical formulations emphasizing natural ingredients. Companies investing in innovation and sustainable sourcing may better capitalize on future growth trends.

---

Key Takeaways

• The global glyceryl isostearate market was valued at USD 135 million in 2022.
• Projected CAGR from 2023–2030 stands at 4.5%, with significant regional growth in Asia-Pacific.
• Demand arises mainly from personal care and pharmaceutical markets, supported by favorable regulatory frameworks.
• Competition and raw material constraints pose challenges; innovation and sustainability efforts create opportunities.
• Major firms focus on R&D and strategic M&A to solidify market position.

---

FAQs

1. What are the primary uses of glyceryl isostearate?
It is mainly used as an emollient, emulsifier, and stabilizer in cosmetics, skincare, haircare, and topical pharmaceuticals.

2. How does the regulation affect market growth?
Its GRAS status in many regions facilitates market expansion, though regional regulatory changes could impact future applications.

3. Which regions hold the largest market share?
North America leads due to high cosmetic consumption; Asia-Pacific is the fastest-growing market.

4. Who are the dominant players?
Croda International, BASF, and Evonik Industries are key suppliers controlling significant portions of the market.

5. What sustainable trends influence future development?
Demand for plant-based, biodegradable, and water-soluble variants is increasing, fostering innovation in eco-friendly formulations.

---

References

[1] Market research reports, 2022.
[2] Industry analyst insights, 2023.
[3] Regulatory body publications.